Related Experiment Video
Updated: May 5, 2026
06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
10.8K
Cyclamen exerts cytotoxicity in solid tumor cell lines: a step toward new anticancer agents?
Mustafa Yildiz1, Hakan Bozcu, Onur Tokgun
1Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey
Asian Pacific Journal of Cancer Prevention : APJCP
|December 3, 2013
Summary
Cyclamen extract shows anticancer potential by inducing cell death in cervical and lung cancer cells. This study reveals its ability to trigger apoptosis, suggesting possibilities for developing new cancer treatments.
Area of Science:
- Pharmacology
- Natural Products
- Oncology
Background:
- Cyclamen coum, a traditional Turkish medicinal plant, has uninvestigated anticancer properties.
- Cytotoxicity of cyclamen extract on solid cancer cell lines is not well-established.
Purpose of the Study:
- To investigate the cytotoxic effects of Cyclamen coum extract on cervical cancer (HeLa) and non-small cell lung cancer (H1299) cell lines.
- To determine if Cyclamen coum extract induces apoptosis in these cancer cells.
Main Methods:
- Treatment of HeLa and H1299 cells with varying doses of Cyclamen coum extract.
- Assessment of cellular death and apoptosis induction using the TUNEL assay.
Main Results:
- Cyclamen coum extract demonstrated dose-dependent cytotoxicity against both HeLa and H1299 cells.
- The extract was confirmed to induce apoptosis in the tested cancer cell lines.
Conclusions:
- Cyclamen coum extract exhibits significant cytotoxicity via apoptosis induction in cervical and non-small cell lung cancer cells.
- These findings suggest Cyclamen coum as a potential source for novel anticancer compounds.
More Related Videos
Related Concept Videos
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:57Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:10Drugs that Destabilize Microtubules
3.2K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.2K
01:15Drugs that Stabilize Microtubules
2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K